ReShape Lifesciences Inc. - RSLS Company Value to Revenue Ratio

Public company logo of ReShape Lifesciences Inc (RSLS)

ReShape Lifesciences specializes in devices for combating metabolic issues and obesity, relying on equipment sales. The logistics of precision parts are secured through assembly diversification and warehouse reserves. The environmental strategy is based on packaging optimization and energy saving. The enterprise valuation via EV/Sales demonstrates the market attractiveness of the asset, where the parameter value equals .

RSLS ReShape Lifesciences Inc.: EV/Sales Multiple in the range 07/04/2022 - 11/20/2026

RSLS (reshapelifesciences.com): analytical breakdowns and indicator data

Fundamental valuation:ReShape Lifesciences, Inc. RSLS
Mass-produced product of ReShape Lifesciences

ReShape Lifesciences' bet on minimally invasive surgery and digital patient support services creates a foundation for stable margin growth. By analyzing the company's EV/Sales multiple on the GURU.Markets platform, an investor assesses the total enterprise value relative to the generated revenue stream. This indicator determines the extent to which the market is willing to pay a premium for the issuer's technological potential compared to current sales volumes.

Competitor analysis for ReShape Lifesciences

Enterprise Value-to-Revenue Multiple DexCom, Inc.|PEN: EV/Sales Multiple|Company Value to Revenue Ratio NOVT|HAE (Haemonetics Company) - EV/Sales Multiple|Inspire Sleep (INSP) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple PRCT|Company Value to Revenue CONMED Corporation CNMD|EV/Sales Multiple PLSE (pulsebiosciences.com)|EV/Sales Multiple InMode Ltd INMD|PMI: Company Value to Revenue|SRDX: Enterprise Value-to-Revenue Ratio|SENS (Senseonics Corp) - Company Value to Revenue|NeuroPace, Inc. - Business Value to Revenue|TCMD (Tactile Systems Technology, Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SANUWAVE Health SNWV|EV/Sales Multiple OM|Electromed Inc (ELMD) - Enterprise Value-to-Sales Ratio|LENSAR Inc - Company Value to Revenue|EV/Sales Multiple AVITA Medical, Inc. RCEL|Profound Medical Corp - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Baird Medical BDMD|EDAP TMS (EDAP) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume APYX (Bovie Medical)|Enterprise Value-to-Revenue Ratio icecure-medical.com|Company Value to Revenue Pulmonx Corporation (LUNG)|EV/Sales Multiple TELA|CTSO - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Sensus Healthcare, Inc. SRTS|ZYXI: Company Value to Revenue Ratio|ECOR: Company Value to Revenue|Vicarious Surgical Inc - Enterprise Value-to-Revenue Coefficient|IINN: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SeaStar Medical (ICU)|Enterprise Value-to-Revenue Ratio iridex.com|Company Value to Revenue Ratio INBS (Intelligent Bio Solutions Inc.)|Company Value to Revenue XAIR (Beyond Air, Inc.)|PFSA - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple SSKN (STRATA Skin Sciences Inc.)|GCTK - Company Value to Revenue|NAOV: Company Value to Revenue|Total Company Value-to-Revenue Ratio Venus Concept Inc. VERO|Nuwellis, Inc. (NUWE) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Multiple aethlonmedical.com (AEMD)|Enterprise Value-to-Revenue Ratio Asensus Surgical|AVGR: Business Value to Revenue|Company Value to Revenue BSGM (BioSig Technologies, Inc.)|Total Company Value-to-Revenue Ratio Cutera Inc|Know Labs, Inc. - Company Value to Revenue|NARI: Company Value to Revenue Ratio|NVRO - Enterprise Value-to-Revenue Ratio|Business Value to Revenue SILK (Silk Road Medical, Inc.)